Systems approaches to dissecting immunity

Current Topics in Microbiology and Immunology

Volumn 363, Issue , 2012, Pages 1-19

  Diercks, Alan ^a   Aderem, Alan ^a  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RIG I LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

ANTIGEN RECOGNITION; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; INNATE IMMUNITY; MACROPHAGE; MALARIA; MOLECULAR INTERACTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VACCINATION;

ANIMALS; HUMANS; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VACCINATION;

EID: 84874979551     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-246     Document Type: Article

References (71)

1. Rappuoli R, Aderem A (2011) A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473(7348): 463-469
2. Alon U (2007) Network motifs: theory and experimental approaches. Nat Rev Genet 8(6): 450-461
3. Zak DE et al (2011) Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. In: Proceedings of the National Academy of Sciences of the United States of America, 2011
4. Underhill DM, Ozinsky A (2002) Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20: 825-852
5. Aderem AA, Scott WA, Cohn ZA (1984) A selective defect in arachidonic acid release from macrophage membranes in high potassium media. J Cell Biol 99(4 Pt 1): 1235-1241
6. Aderem AA (1985) Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J Exp Med 161(3): 617-622
7. Aderem AA (1986) Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 164(1): 165-179
8. Goodridge HS, Underhill DM (2008) Fungal Recognition by TLR2 and Dectin-1. Handb Exp Pharmacol 183: 87-109
9. Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304(5673): 1014-1018
10. Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440(7085): 808-812
11. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3): 179-190
12. Miao EA et al (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7(6): 569-575
13. Geddes BJ et al (2001) Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem Biophys Res Commun 284(1): 77-82
14. Poyet JL et al (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276(30): 28309-28313
15. Masumoto J et al (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303(1): 69-73
16. Dinarello CA (1998) Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 856: 1-11
17. Miao EA (2007) TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol 29(3): 275-288
18. Stetson DB, Medzhitov R (2006) Type I interferons in host defense. Immunity 25(3): 373-381
19. Kumar H et al (2008) Cutting edge: cooperation of IPS-1-and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 180(2): 683-687
20. Edelmann KH (2004) Does Toll-like receptor 3 play a biological role in virus infections? Virology 322(2): 231-238
21. Warren SE (2008) Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 180(11): 7558-7564
22. Roach JC (2005) The evolution of vertebrate Toll-like receptors. Proc Nat Acad Sci USA 102(27): 9577-9582
23. Jin MS, Lee JO (2008) Structures of TLR-ligand complexes. Curr Opin Immunol 20(4): 414-419
24. Jin MS (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130(6): 1071-1082
25. Liu L (2008) Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320(5874): 379-381
26. Honda K, Takaoka A, Taniguchi T (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3): 349-360
27. Liew FY (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5(6): 446-458
28. Boone DL (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5(10): 1052-1060
29. Wang YY (2004) A20 is a potent inhibitor of TLR3-and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett 576(1-2): 86-90
30. Saitoh T (2005) A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol 174(3): 1507-1512
31. Lin R (2006) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281(4): 2095-2103
32. Hitotsumatsu O (2008) The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligo-merization domain containing 2-triggered signals. Immunity 28(3): 381-390
33. Bolouri H, Davidson EH (2003) Transcriptional regulatory cascades in development: initial rates, not steady state, determine network kinetics. Proc Nat Acad Sci USA 100(16): 9371-9376
34. Smith J, Theodoris C, Davidson EH (2007) A gene regulatory network subcircuit drives a dynamic pattern of gene expression. Science 318(5851): 794-797
35. Seymour RE (2007) Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun 8(5): 416-421
36. Zenewicz LA, Shen H (2007) Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infection/Institut Pasteur 9(10): 1208-1215
37. Warren SE (2010) Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2. J Immunol 185(2): 818-821
38. Leber JH (2008) Distinct TLR-and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 4(1): e6
39. Vadigepalli R (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7(3): 235-252
40. Subramanian A (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci USA 102(43): 15545-15550
41. Siggs OM (2010) A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha. Proc Nat Acad Sci USA 107(7): 3046-3051
42. Lim S (2001) Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol Cell Neurosci 17(2): 385-397
43. Tokunaga F (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11(2): 123-132
44. Gerlach B (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471(7340): 591-596
45. Ikeda F (2011) Sharpin forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471(7340): 637-641
46. Tokunaga F (2011) Sharpin is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471(7340): 633-636
47. Amit I (2009) Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326(5950): 257-263
48. Zak DE (2011) Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc Natl Acad Sci USA 108(28): 11536-11541
49. Litvak V (2009) Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 10(4): 437-443
50. Ramsey SA (2008) Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics. PLoS Comput Biol 4(3): e1000021.
51. Gilchrist M (2006) Systems biology approaches identify ATF3 as a negative regulator of Tolllike receptor 4. Nature 441(7090): 173-178
52. Suzuki H (2009) The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 41(5): 553-562
53. Querec TD (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10(1): 116-125
54. Gaucher D (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205(13): 3119-3131
55. Nakaya HI (2011) Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12(8): 786-795
56. Pulendran B, Li S, Nakaya HI (2010) Systems vaccinology. Immunity 33(4): 516-529
57. Zak DE, Aderem A (2009) Systems biology of innate immunity. Immunol Rev 227(1): 264-282
58. Shapira SD, Hacohen N (2011) Systems biology approaches to dissect mammalian innate immunity. Curr Opin Immunol 23(1): 71-77
59. Gardy JL (2009) Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol 30(6): 249-262
60. Bosinger SE (2009) Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119(12): 3556-3572
61. Palermo RE (2011) Genomic analysis reveals pre-and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy. J Virol 85(2): 1099-1116
62. Hersperger AR (2011) Qualitative features of the HIV-specific CD8 ? T-cell response associated with immunologic control. Curr Opin HIV AIDS 6(3): 169-173
63. Querec T (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203(2): 413-424
64. Lindsay RW (2010) CD8 ? T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c ? dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 185(3): 1513-1521
65. Delaloye J (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 5(6): e1000480
66. Brooks JPL (2008) E.K., Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann Oper Res 1-64: 1-20
67. Zou HH, Hastie T (2005) Regularization and variable selection via the elastic net. J R Stat Soc B. 67(Part 2): 301-320
68. Araki K (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460(7251): 108-112
69. Tan X (2011) Retinoic acid as a vaccine adjuvant enhances CD8 ? T cell response and mucosal protection from viral challenge. J Virol 85(16): 8316-8327
70. Freidlin B, Simon R (2005) Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clin Cancer Res: An Off J Am Assoc Cancer Res 11(21): 7872-7878
71. Campbell H (2009) Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 27(Suppl 2): B20-B29